{"entity":{"type":"insider","cik":"0001822879","url":"/insider/0001822879","json_url":"/insider/0001822879.json","name":"Leonard Frank X","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":32,"first":"2021-03-04","last":"2026-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Leonard Frank X","source":"filing","n_filings":32,"first_seen":"2021-03-04","last_seen":"2026-06-05"}],"transactions":[{"id":5865615,"accession":"0001822879-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001822879-26-000004","line_url":"/filing/0001822879-26-000004#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34273.0,"shares_display":"34,273","price_per_share":17.9335,"price_display":"17.93","price_state":"stated","total_value":614634.8455,"total_display":"614,634.85","total_whole":"614,635","shares_owned_after":459520.0,"shares_owned_after_display":"459,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-04","filed_date":"2026-06-05","scope":"insider"},{"id":6180743,"accession":"0001822879-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001822879-26-000003","line_url":"/filing/0001822879-26-000003#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5607.0,"shares_display":"5,607","price_per_share":13.3054,"price_display":"13.31","price_state":"stated","total_value":74603.3778,"total_display":"74,603.38","total_whole":"74,603","shares_owned_after":493793.0,"shares_owned_after_display":"493,793","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-05","scope":"insider"},{"id":6082163,"accession":"0001822879-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001822879-26-000002","line_url":"/filing/0001822879-26-000002#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7232.0,"shares_display":"7,232","price_per_share":13.493,"price_display":"13.49","price_state":"stated","total_value":97581.376,"total_display":"97,581.38","total_whole":"97,581","shares_owned_after":349400.0,"shares_owned_after_display":"349,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":6082156,"accession":"0001822879-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001822879-26-000002","line_url":"/filing/0001822879-26-000002#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9734.0,"shares_display":"9,734","price_per_share":13.6638,"price_display":"13.66","price_state":"stated","total_value":133003.4292,"total_display":"133,003.43","total_whole":"133,003","shares_owned_after":338011.0,"shares_owned_after_display":"338,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider"},{"id":4045995,"accession":"0001562180-25-004426","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-004426","line_url":"/filing/0001562180-25-004426","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30196.0,"shares_display":"30,196","price_per_share":17.499423436879056,"price_display":"17.50","price_state":"stated","total_value":528412.5901,"total_display":"528,412.59","total_whole":"528,413","shares_owned_after":176931.0,"shares_owned_after_display":"176,931","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider","n_lines":3},{"id":4821300,"accession":"0001562180-25-001976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-001976","line_url":"/filing/0001562180-25-001976#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2527.0,"shares_display":"2,527","price_per_share":18.5363,"price_display":"18.54","price_state":"stated","total_value":46841.2301,"total_display":"46,841.23","total_whole":"46,841","shares_owned_after":143673.0,"shares_owned_after_display":"143,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-04","scope":"insider"},{"id":4443262,"accession":"0001562180-25-001834","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-001834","line_url":"/filing/0001562180-25-001834#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2770.0,"shares_display":"2,770","price_per_share":18.2843,"price_display":"18.28","price_state":"stated","total_value":50647.511,"total_display":"50,647.51","total_whole":"50,648","shares_owned_after":146200.0,"shares_owned_after_display":"146,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":4288847,"accession":"0001562180-25-001915","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-25-001915","line_url":"/filing/0001562180-25-001915#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2770.0,"shares_display":"2,770","price_per_share":18.2843,"price_display":"18.28","price_state":"stated","total_value":50647.511,"total_display":"50,647.51","total_whole":"50,648","shares_owned_after":146200.0,"shares_owned_after_display":"146,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-28","filed_date":"2025-03-03","scope":"insider"},{"id":4443258,"accession":"0001562180-25-001834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001834","line_url":"/filing/0001562180-25-001834","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12266.0,"shares_display":"12,266","price_per_share":20.023587746616663,"price_display":"20.02","price_state":"stated","total_value":245609.3273,"total_display":"245,609.33","total_whole":"245,609","shares_owned_after":150959.0,"shares_owned_after_display":"150,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider","n_lines":2},{"id":4288843,"accession":"0001562180-25-001915","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-25-001915","line_url":"/filing/0001562180-25-001915","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12266.0,"shares_display":"12,266","price_per_share":20.023587746616663,"price_display":"20.02","price_state":"stated","total_value":245609.3273,"total_display":"245,609.33","total_whole":"245,609","shares_owned_after":150959.0,"shares_owned_after_display":"150,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-27","filed_date":"2025-03-03","scope":"insider","n_lines":2},{"id":2565996,"accession":"0001562180-24-007516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-007516","line_url":"/filing/0001562180-24-007516#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":598.0,"shares_display":"598","price_per_share":15.9377,"price_display":"15.94","price_state":"stated","total_value":9530.7446,"total_display":"9,530.74","total_whole":"9,531","shares_owned_after":161236.0,"shares_owned_after_display":"161,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-01","filed_date":"2024-11-04","scope":"insider"},{"id":2219174,"accession":"0001562180-24-002247","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-002247","line_url":"/filing/0001562180-24-002247#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":840.0,"shares_display":"840","price_per_share":16.01,"price_display":"16.01","price_state":"stated","total_value":13448.4,"total_display":"13,448.40","total_whole":"13,448","shares_owned_after":160098.0,"shares_owned_after_display":"160,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":2219172,"accession":"0001562180-24-002247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-002247","line_url":"/filing/0001562180-24-002247#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1679.0,"shares_display":"1,679","price_per_share":16.0269,"price_display":"16.03","price_state":"stated","total_value":26909.1651,"total_display":"26,909.17","total_whole":"26,909","shares_owned_after":160938.0,"shares_owned_after_display":"160,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":3207425,"accession":"0001562180-24-001988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-24-001988","line_url":"/filing/0001562180-24-001988#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (EVP, Pres., Novocure Oncology)","role_mark":"O","role_mark_label":"Officer (EVP, Pres., Novocure Oncology)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pres., Novocure Oncology","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2078.0,"shares_display":"2,078","price_per_share":16.1428,"price_display":"16.14","price_state":"stated","total_value":33544.7384,"total_display":"33,544.74","total_whole":"33,545","shares_owned_after":162617.0,"shares_owned_after_display":"162,617","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-29","scope":"insider"},{"id":7943777,"accession":"0001562180-23-002581","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-23-002581","line_url":"/filing/0001562180-23-002581","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8318.0,"shares_display":"8,318","price_per_share":75.16292448905988,"price_display":"75.16","price_state":"stated","total_value":625205.2059,"total_display":"625,205.21","total_whole":"625,205","shares_owned_after":56599.0,"shares_owned_after_display":"56,599","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-07","scope":"insider","n_lines":2},{"id":8170411,"accession":"0001562180-23-002489","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-002489","line_url":"/filing/0001562180-23-002489#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2059.0,"shares_display":"2,059","price_per_share":77.6391,"price_display":"77.64","price_state":"stated","total_value":159858.9069,"total_display":"159,858.91","total_whole":"159,859","shares_owned_after":67893.0,"shares_owned_after_display":"67,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-06","scope":"insider"},{"id":7943771,"accession":"0001562180-23-002581","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-002581","line_url":"/filing/0001562180-23-002581","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5291.0,"shares_display":"5,291","price_per_share":76.1594,"price_display":"76.16","price_state":"stated","total_value":402959.3854,"total_display":"402,959.39","total_whole":"402,959","shares_owned_after":63490.0,"shares_owned_after_display":"63,490","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider","n_lines":2},{"id":8688091,"accession":"0001562180-23-002359","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-002359","line_url":"/filing/0001562180-23-002359","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4107.0,"shares_display":"4,107","price_per_share":75.37806557097637,"price_display":"75.38","price_state":"stated","total_value":309577.7153,"total_display":"309,577.72","total_whole":"309,578","shares_owned_after":59296.0,"shares_owned_after_display":"59,296","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-03","scope":"insider","n_lines":2},{"id":8170405,"accession":"0001562180-23-002489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002489","line_url":"/filing/0001562180-23-002489#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":844.0,"shares_display":"844","price_per_share":75.2779,"price_display":"75.28","price_state":"stated","total_value":63534.5476,"total_display":"63,534.55","total_whole":"63,535","shares_owned_after":58144.0,"shares_owned_after_display":"58,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":8409203,"accession":"0001645113-23-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-23-000031","line_url":"/filing/0001645113-23-000031#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1684.0,"shares_display":"1,684","price_per_share":76.3624,"price_display":"76.36","price_state":"stated","total_value":128594.2816,"total_display":"128,594.28","total_whole":"128,594","shares_owned_after":63095.0,"shares_owned_after_display":"63,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8409188,"accession":"0001645113-23-000009","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001645113-23-000009","line_url":"/filing/0001645113-23-000009","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39507.0,"shares_display":"39,507","price_per_share":112.24983115903511,"price_display":"112.25","price_state":"stated","total_value":4434654.0796,"total_display":"4,434,654.08","total_whole":"4,434,654","shares_owned_after":46158.0,"shares_owned_after_display":"46,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider","n_lines":9},{"id":6610840,"accession":"0001645113-22-000086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000086","line_url":"/filing/0001645113-22-000086#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6754.0,"shares_display":"6,754","price_per_share":76.01,"price_display":"76.01","price_state":"stated","total_value":513371.54,"total_display":"513,371.54","total_whole":"513,372","shares_owned_after":43626.0,"shares_owned_after_display":"43,626","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6733311,"accession":"0001645113-22-000085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000085","line_url":"/filing/0001645113-22-000085#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6754.0,"shares_display":"6,754","price_per_share":84.37,"price_display":"84.37","price_state":"stated","total_value":569834.98,"total_display":"569,834.98","total_whole":"569,835","shares_owned_after":50380.0,"shares_owned_after_display":"50,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-07","scope":"insider"},{"id":6871088,"accession":"0001645113-22-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000084","line_url":"/filing/0001645113-22-000084#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6754.0,"shares_display":"6,754","price_per_share":77.35,"price_display":"77.35","price_state":"stated","total_value":522421.9,"total_display":"522,421.90","total_whole":"522,422","shares_owned_after":57134.0,"shares_owned_after_display":"57,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-30","scope":"insider"},{"id":6831068,"accession":"0001645113-22-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000083","line_url":"/filing/0001645113-22-000083#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (President, CNS Cancers US)","role_mark":"O","role_mark_label":"Officer (President, CNS Cancers US)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CNS Cancers US","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6754.0,"shares_display":"6,754","price_per_share":77.0,"price_display":"77.00","price_state":"stated","total_value":520058.0,"total_display":"520,058.00","total_whole":"520,058","shares_owned_after":63888.0,"shares_owned_after_display":"63,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-26","scope":"insider"},{"id":6357752,"accession":"0001645113-22-000082","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-22-000082","line_url":"/filing/0001645113-22-000082","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12271.0,"shares_display":"12,271","price_per_share":88.51941488061283,"price_display":"88.52","price_state":"stated","total_value":1086221.74,"total_display":"1,086,221.74","total_whole":"1,086,222","shares_owned_after":76159.0,"shares_owned_after_display":"76,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider","n_lines":2},{"id":6499648,"accession":"0001645113-22-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000080","line_url":"/filing/0001645113-22-000080#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1863.0,"shares_display":"1,863","price_per_share":88.0,"price_display":"88.00","price_state":"stated","total_value":163944.0,"total_display":"163,944.00","total_whole":"163,944","shares_owned_after":84150.0,"shares_owned_after_display":"84,150","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-09","filed_date":"2022-09-12","scope":"insider"},{"id":9294057,"accession":"0001645113-22-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000081","line_url":"/filing/0001645113-22-000081#line-1","is_derivative":false,"issuer_cik":"0001822879","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001822879","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6754.0,"shares_display":"6,754","price_per_share":81.48,"price_display":"81.48","price_state":"stated","total_value":550315.92,"total_display":"550,315.92","total_whole":"550,316","shares_owned_after":77396.0,"shares_owned_after_display":"77,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-08","filed_date":"2022-09-13","scope":"insider"},{"id":6733309,"accession":"0001645113-22-000079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000079","line_url":"/filing/0001645113-22-000079#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1384.0,"shares_display":"1,384","price_per_share":78.57,"price_display":"78.57","price_state":"stated","total_value":108740.88,"total_display":"108,740.88","total_whole":"108,741","shares_owned_after":86013.0,"shares_owned_after_display":"86,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider"},{"id":6706564,"accession":"0001645113-22-000074","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001645113-22-000074","line_url":"/filing/0001645113-22-000074#line-13","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":584.0,"shares_display":"584","price_per_share":79.037,"price_display":"79.04","price_state":"stated","total_value":46157.608,"total_display":"46,157.61","total_whole":"46,158","shares_owned_after":87397.0,"shares_owned_after_display":"87,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6706561,"accession":"0001645113-22-000074","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001645113-22-000074","line_url":"/filing/0001645113-22-000074#line-12","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2955.0,"shares_display":"2,955","price_per_share":78.085,"price_display":"78.08","price_state":"stated","total_value":230741.175,"total_display":"230,741.18","total_whole":"230,741","shares_owned_after":96277.0,"shares_owned_after_display":"96,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6706559,"accession":"0001645113-22-000074","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001645113-22-000074","line_url":"/filing/0001645113-22-000074#line-11","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2720.0,"shares_display":"2,720","price_per_share":77.917,"price_display":"77.92","price_state":"stated","total_value":211934.24,"total_display":"211,934.24","total_whole":"211,934","shares_owned_after":90155.0,"shares_owned_after_display":"90,155","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6706557,"accession":"0001645113-22-000074","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001645113-22-000074","line_url":"/filing/0001645113-22-000074#line-10","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1914.0,"shares_display":"1,914","price_per_share":77.002,"price_display":"77.00","price_state":"stated","total_value":147381.828,"total_display":"147,381.83","total_whole":"147,382","shares_owned_after":99232.0,"shares_owned_after_display":"99,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"},{"id":6706554,"accession":"0001645113-22-000074","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001645113-22-000074","line_url":"/filing/0001645113-22-000074#line-9","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001822879","owner_name":"Leonard Frank X","owner_display_name":"Leonard Frank X","owner_url":"/insider/0001822879","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1750.0,"shares_display":"1,750","price_per_share":76.958,"price_display":"76.96","price_state":"stated","total_value":134676.5,"total_display":"134,676.50","total_whole":"134,677","shares_owned_after":92875.0,"shares_owned_after_display":"92,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-01","filed_date":"2022-09-06","scope":"insider"}],"collapsed":true,"next_cursor":"2022-09-01|6706554","ledger_fault":false,"count":{"value":68,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":68,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":68},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Officer (Chief Executive Officer)","n_filings":32,"first_seen":"2021-03-04","last_seen":"2026-06-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001822879","retrieved_at":"2026-08-24T21:50:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}